Literature DB >> 20559789

18F-FET-PET-based dose painting by numbers with protons.

Mark Rickhey1, Zdenek Morávek, Christoph Eilles, Oliver Koelbl, Ludwig Bogner.   

Abstract

PURPOSE: To investigate the potential of (18)F-fluoroethyltyrosine-positron emission tomography-((18)F-FET-PET-)based dose painting by numbers with protons.
MATERIAL AND METHODS: Due to its high specificity to brain tumor cells, FET has a high potential to serve as a target for dose painting by numbers. Biological image-based dose painting might lead to an inhomogeneous dose prescription. For precise treatment planning of such a prescribed dose, an intensity-modulated radiotherapy (IMRT) algorithm including a Monte Carlo dose-calculation algorithm for spot-scanning protons was used. A linear tracer uptake to dose model was used to derive a dose prescription from the (18)F-FET-PET. As a first investigation, a modified modulation transfer function (MTF) of protons was evaluated and compared to the MTF of photons. In a clinically adapted planning study, the feasibility of (18)F-FET-PET-based dose painting with protons was demonstrated using three patients with glioblastome multiforme. The resulting dose distributions were evaluated by means of dose-difference and dose-volume histograms and compared to IMRT data.
RESULTS: The MTF for protons was constantly above that for photons. The standard deviations of the dose differences between the prescribed and the optimized dose were smaller in case of protons compared to photons. Furthermore, the escalation study showed that the doses within the subvolumes identified by biological imaging techniques could be escalated remarkably while the dose within the organs at risk was kept at a constant level.
CONCLUSION: The presented investigation fortifies the feasibility of (18)F-FET-PET-based dose painting with protons.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559789     DOI: 10.1007/s00066-010-2014-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  35 in total

1.  Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm.

Authors:  M Fippel
Journal:  Med Phys       Date:  1999-08       Impact factor: 4.071

2.  Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams.

Authors:  E Pedroni; S Scheib; T Böhringer; A Coray; M Grossmann; S Lin; A Lomax
Journal:  Phys Med Biol       Date:  2005-02-07       Impact factor: 3.609

3.  Application of the inverse Monte Carlo treatment planning system IKO for an inhomogeneous dose prescription in the sense of dose painting.

Authors:  Mark Rickhey; Ludwig Bogner
Journal:  Z Med Phys       Date:  2006       Impact factor: 4.820

4.  Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.

Authors:  Christine Heisterkamp; Tiina Haatanen; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2010-01-26       Impact factor: 3.621

5.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

6.  Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study.

Authors:  Claudio Fiorino; Italo Dell'Oca; Alessio Pierelli; Sara Broggi; Giovanni Mauro Cattaneo; Anna Chiara; Elena De Martin; Nadia Di Muzio; Ferruccio Fazio; Riccardo Calandrino
Journal:  Strahlenther Onkol       Date:  2007-09       Impact factor: 3.621

7.  A Monte Carlo dose calculation algorithm for proton therapy.

Authors:  Matthias Fippel; Martin Soukup
Journal:  Med Phys       Date:  2004-08       Impact factor: 4.071

8.  Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer.

Authors:  Changlu Wang; Hidetsugu Nakayama; Shinji Sugahara; Takeji Sakae; Koichi Tokuuye
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

9.  Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment.

Authors:  N G Burnet; R Jena; S J Jefferies; S P Stenning; N F Kirkby
Journal:  Clin Oncol (R Coll Radiol)       Date:  2006-03       Impact factor: 4.126

10.  Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons.

Authors:  Zahra Taheri-Kadkhoda; Thomas Björk-Eriksson; Simeon Nill; Jan J Wilkens; Uwe Oelfke; Karl-Axel Johansson; Peter E Huber; Marc W Münter
Journal:  Radiat Oncol       Date:  2008-01-24       Impact factor: 3.481

View more
  8 in total

1.  Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.

Authors:  M D Piroth; M Pinkawa; R Holy; J Klotz; S Schaar; G Stoffels; N Galldiks; H H Coenen; H J Kaiser; K J Langen; M J Eble
Journal:  Strahlenther Onkol       Date:  2012-02-22       Impact factor: 3.621

2.  Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer. A case report.

Authors:  M Schaffer; A Hofstetter; B Ertl-Wagner; R Batash; J Pöschl; P M Schaffer
Journal:  Strahlenther Onkol       Date:  2013-10-26       Impact factor: 3.621

3.  [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Authors:  Markus Hutterer; Martha Nowosielski; Daniel Putzer; Nathalie L Jansen; Marcel Seiz; Michael Schocke; Mark McCoy; Georg Göbel; Christian la Fougère; Irene J Virgolini; Eugen Trinka; Andreas H Jacobs; Günther Stockhammer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

4.  Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine positron emission tomography.

Authors:  Robert Kosztyla; Srinivas Raman; Vitali Moiseenko; Stefan A Reinsberg; Brian Toyota; Alan Nichol
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

Review 5.  Visualization, imaging and new preclinical diagnostics in radiation oncology.

Authors:  Clemens C Cyran; Philipp M Paprottka; Michel Eisenblätter; Dirk A Clevert; Carsten Rist; Konstantin Nikolaou; Kirsten Lauber; Frederik Wenz; Daniel Hausmann; Maximilian F Reiser; Claus Belka; Maximilian Niyazi
Journal:  Radiat Oncol       Date:  2014-01-03       Impact factor: 3.481

Review 6.  Amino acid PET and MR perfusion imaging in brain tumours.

Authors:  Christian P Filss; Francesco Cicone; Nadim Jon Shah; Norbert Galldiks; Karl-Josef Langen
Journal:  Clin Transl Imaging       Date:  2017-03-13

7.  Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI.

Authors:  E J Her; A Haworth; H M Reynolds; Y Sun; A Kennedy; V Panettieri; M Bangert; S Williams; M A Ebert
Journal:  Radiat Oncol       Date:  2020-07-13       Impact factor: 3.481

8.  Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.

Authors:  F Walter; C la Fougère; C Belka; M Niyazi
Journal:  Front Oncol       Date:  2012-10-04       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.